DSD-T345
Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T345
Suspected 17α-hydroxylase deficiency (partial form, a rare form of 46,XX DSD/CAH) with autoimmune adrenalitis, presenting as primary infertility.
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia (CAH)
- Age
-
32 years
- Sex
-
Female
- Karyotype
-
46,XY
- Genetics
-
AR
- Diagnosis
-
Suspected 17α-hydroxylase deficiency (partial form, a rare form of 46,XX DSD/CAH) with autoimmune adrenalitis, presenting as primary infertility.
- Follow-up
-
Delivered two healthy female infants at term; 1 year postpartum, blood pressure normal, menses regular, adrenal atrophy, and 21-hydroxylase antibodies elevated.
- General phenotype
-
Female phenotype, no abnormal clinical findings, no hyperandrogenism, no hypertension or hypokalemia.
- Imaging
-
Transvaginal ultrasound: normal uterus, proliferative-phase endometrium, antral follicle count 9, dominant follicle seen on day 12; hysterosalpingo-contrast sonography showed left tubal obstruction; adrenal CT showed 5/5 mm and 9/6 mm nodules in the right adrenal gland (possible adenomas), and postpartum follow-up showed adrenal atrophy; breast ultrasound normal.
- Laboratory findings
-
Early follicular 17-OHP 12.3–15.6 ng/mL (normal 0.1–0.8); cortisol 5.68 μg/dL (5–25), ACTH >2000 pg/mL (7.2–63.3); total testosterone 6.38 ng/mL (8.4–48.31, low), DHEAS 6.3 μg/dL (98.8–340, low); 11-deoxycorticosterone 0.26 μg/L (<0.16, mildly elevated); aldosterone 1.92 ng/dL (2.52–39.2) and direct renin 2 μIU/mL (4.4–46.1), both decreased; FSH 7.42 mIU/mL, LH 8.32 mIU/mL, E2 144.4 pg/mL; serum sodium 130 mmol/L, serum potassium 4.6 mmol/L; TSH 2.49 μIU/mL, FT4 1.44 ng/dL; AMH 0.74 ng/mL; 250 μg Synacthen test: cortisol 5.35 μg/dL, 17-OHP 12.92 ng/mL, 11-DOC 0.36 μg/L; 21-hydroxylase antibody 66.3 (<10).
- Management
-
Hydrocortisone 25 mg/day orally for 2 months (ACTH decreased to 370 pg/mL, progesterone remained 1.8 ng/mL); switched to dexamethasone 0.75 mg/day, after which progesterone normalized (0.21 ng/mL); GnRH agonist 3.75 mg for downregulation, estradiol 6 mg/day for endometrial preparation, vaginal progesterone 600 mg/day, and frozen-thawed blastocyst transfer; hydrocortisone 25 mg/day during pregnancy.
- Pathology
-
Not reported in the original article
- Evidence level
-
See source
- Clinical history
-
See source
- Family history
-
See source
- Growth and development
-
See source
- External genital examination
-
See source
- Puberty / Tanner
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XY · DSD-T345 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T345?version=v1.4.0